Adcock Richard

ImmunityBio, Inc. · CEO & President

Adcock Richard is listed in public filings as director, officer: CEO & President. This Adcock Richard insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include ImmunityBio, Inc. (IBRX). Investors use Adcock Richard's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
ImmunityBio, Inc.IBRX$4.9M560.3k sharesGrant / ExerciseFeb 22, 2026$674.8K77.6k shares$8.70--
ImmunityBio, Inc.IBRX--152.4k sharesGrant / ExerciseFeb 22, 2026Disclosure amount unavailable152.4k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
ImmunityBio, Inc.IBRX$3.4M485.5k sharesGrant / ExerciseFeb 10, 2026$970.5K140k shares$6.93--
ImmunityBio, Inc.IBRX--548.2k sharesGrant / ExerciseFeb 10, 2026Disclosure amount unavailable274.1k shares----
ImmunityBio, Inc.IBRX--51.7k sharesGrant / ExerciseDec 31, 2025Disclosure amount unavailable34.5k shares----
ImmunityBio, Inc.IBRX$696k351.4k sharesGrant / ExerciseDec 31, 2025$34.7K17.5k shares$1.98--
ImmunityBio, Inc.IBRX$1.1M334.4k sharesGrant / ExerciseFeb 22, 2025$267.3K78.2k shares$3.42--
ImmunityBio, Inc.IBRX--304.9k sharesGrant / ExerciseFeb 22, 2025Disclosure amount unavailable152.4k shares----
ImmunityBio, Inc.IBRX$9.5M2.8M sharesGrant / ExerciseFeb 10, 2025$9.5M2.8M shares$3.39--
ImmunityBio, Inc.IBRX--822.4k sharesGrant / ExerciseFeb 10, 2025Disclosure amount unavailable822.4k shares----
ImmunityBio, Inc.IBRX--86.2k sharesGrant / ExerciseDec 31, 2024Disclosure amount unavailable34.5k shares----
ImmunityBio, Inc.IBRX$666k260.1k sharesGrant / ExerciseDec 31, 2024$44.7K17.5k shares$2.56--